Attitudes regarding chronic fatigue syndrome: the importance of a name.
Jason, L A, Taylor, R R, Stepanek, Z et al. · Journal of health psychology · 2001 · DOI
Quick Summary
This study found that what doctors and students call ME/CFS affects how they think about the condition. When it was called "myalgic encephalopathy," people were more likely to believe it had a physical cause in the body. The name used also influenced whether healthcare workers thought patients were truly ill or just depressed. This suggests that even the language we use to describe ME/CFS can shape people's beliefs about how serious it is and how it should be treated.
Why It Matters
This research demonstrates that the terminology used to describe ME/CFS significantly influences healthcare providers' understanding and beliefs about the condition, which directly impacts patient care, support, and treatment recommendations. For patients advocating for recognition, these findings show that using biomedically-grounded language like myalgic encephalopathy may help shift provider perception toward accepting the condition as a physical illness rather than psychiatric. Understanding how language shapes provider attitudes is crucial for improving patient care and reducing stigma.
Observed Findings
Participants shown the "myalgic encephalopathy" label attributed more biomedical causes to the illness compared to the "chronic fatigue syndrome" label
Medical trainees were less likely to perceive patients as malingering but more likely to misattribute the condition to primary depression
The label used affected whether participants considered the patient as an appropriate organ donor
Medical trainees perceived worse quality of life outcomes and poorer prognosis than non-medical undergraduates
Medical trainees rated cognitive symptoms as less severe than non-medical participants
Inferred Conclusions
The name or terminology used to describe ME/CFS influences healthcare providers' causal attributions and clinical judgments about the condition
Medical training does not necessarily eliminate misconceptions about ME/CFS, and may in some cases reinforce inappropriate psychiatric attributions
Using biomedically-oriented terminology may help shift provider perception away from psychological interpretations
Standardized naming conventions in medical education and practice may be important for reducing variability in how providers understand and treat ME/CFS
Remaining Questions
Does changing the name used in clinical practice actually lead to improved patient outcomes and better treatment decisions in real-world medical settings?
What This Study Does Not Prove
This study does not prove that changing the name of ME/CFS will automatically change clinical practice or improve patient outcomes in real-world settings. The study used hypothetical vignettes with undergraduate and medical trainees rather than established clinicians making actual treatment decisions, so results may not reflect real clinical behavior. Correlation between naming and attitudes does not establish whether the name itself causes attitude changes or if other factors associated with different terminologies drive the observed differences.
What drives medical trainees' tendency to attribute ME/CFS to primary depression despite recognizing severe physical symptoms and poor prognosis?
How stable are these attitude differences over time, and do they persist after exposure to scientific evidence about ME/CFS pathophysiology?
Which naming convention (if any) best reflects current understanding of ME/CFS biology and would most effectively improve provider and public perception?